ESSA Pharma Inc
NASDAQ:EPIX
ESSA Pharma Inc
Short-Term Investments
ESSA Pharma Inc
Short-Term Investments Peer Comparison
Competitive Short-Term Investments Analysis
Latest Figures & CAGR of Competitors
Company | Short-Term Investments | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
ESSA Pharma Inc
NASDAQ:EPIX
|
Short-Term Investments
$106.8m
|
CAGR 3-Years
69%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Zymeworks Inc
NYSE:ZYME
|
Short-Term Investments
$216.8m
|
CAGR 3-Years
6%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
Repare Therapeutics Inc
NASDAQ:RPTX
|
Short-Term Investments
$112.4m
|
CAGR 3-Years
147%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
|
Short-Term Investments
$172.2m
|
CAGR 3-Years
9%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
Short-Term Investments
$255.5m
|
CAGR 3-Years
10%
|
CAGR 5-Years
130%
|
CAGR 10-Years
20%
|
|
Spectral Medical Inc
TSX:EDT
|
Short-Term Investments
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is ESSA Pharma Inc's Short-Term Investments?
Short-Term Investments
106.8m
USD
Based on the financial report for Dec 31, 2023, ESSA Pharma Inc's Short-Term Investments amounts to 106.8m USD.
What is ESSA Pharma Inc's Short-Term Investments growth rate?
Short-Term Investments CAGR 3Y
69%
Over the last year, the Short-Term Investments growth was -5%. The average annual Short-Term Investments growth rates for ESSA Pharma Inc have been 69% over the past three years .